Scientific article indicated that the combination therapy regimen could promote ROS accumulation, enhance oxidative stress, and induce apoptosis as well as block mitosis in G2/M phase in both tumor cells, partially due to repression of Nrf2 and Nrf2-dependent effectors [95]. This evidence concerns the gene NFE2L2 and neoplasm.